Changes in Director's Interest (Section 219 of CA 2016)
| IHH HEALTHCARE BERHAD |
Information Compiled By KLSE
Particulars of Director
| Name | MR MEHMET ALI AYDINLAR |
| Descriptions(Class) | Ordinary shares |
Details of changes
| No | Date of change |
No of securities |
Type of transaction |
Nature of Interest |
|
01/09/2026
|
405,100
|
Acquired
|
Indirect Interest
|
|
| Name of registered holder | Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA | |||
| Description of "Others" Type of Transaction | ||||
| Consideration (if any) | RM8.15 | |||
| Circumstances by reason of which change has occurred | Acquisition through open market |
| Nature of interest | Direct and Indirect Interest |
Total no of securities after change |
|
| Direct (units) | 7,948,000 |
| Direct (%) | 0.090 |
| Indirect/deemed interest (units) | 507,626,673 |
| Indirect/deemed interest (%) | 5.745 |
| Date of notice | 04/09/2026 |
| Date notice received by Listed Issuer | 04/09/2026 |
| Remarks : |
| SZA stands for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi. Total no. of securities held by Mr. Mehmet Ali Aydinlar after change includes:- Direct Interest 1) Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG (7,000,000 ordinary shares) 2) Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for Mehmet Ali Aydinlar (948,000 ordinary shares) Indirect Interest 1) Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG (7,000,000 ordinary shares) 2) Citibank Nominees Singapore Pte Ltd (207,620,000 ordinary shares) 3) Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA (293,006,673 ordinary shares) |
Announcement Info
| Company Name | IHH HEALTHCARE BERHAD |
| Stock Name | IHH |
| Date Announced | 04 Sep 2026 |
| Category | Changes in Director's Interest Pursuant to Section 219 of CA 2016 |
| Reference Number | CS4-04092026-00030 |